VENKYS (INDIA)
Back to Balance Sheet
|
VENKYS (INDIA) Last 5 Year Total Current Liabilities History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Current Liabilities | ₹666 Cr | ₹665 Cr | ₹641 Cr | ₹626 Cr | ₹705 Cr |
What is the latest Total Current Liabilities ratio of VENKYS (INDIA) ?
Year | Total Current Liabilities |
---|---|
Mar2024 | ₹666 Cr |
Mar2023 | ₹665 Cr |
Mar2022 | ₹641 Cr |
Mar2021 | ₹626 Cr |
Mar2020 | ₹705 Cr |
How is Total Current Liabilities of VENKYS (INDIA) Trending?
Years | Total Current Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹666 Cr | 0.20 | |
Mar2023 | ₹665 Cr | 3.62 | |
Mar2022 | ₹641 Cr | 2.47 | |
Mar2021 | ₹626 Cr | -11.28 | |
Mar2020 | ₹705 Cr | - |
Compare Total Current Liabilities of peers of VENKYS (INDIA)
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
VENKYS (INDIA) | ₹2,394.2 Cr | -1.6% | 1% | -2.2% | Stock Analytics | |
BOMBAY BURMAH TRADING CORPORATION | ₹13,295.0 Cr | -0.8% | 6.7% | 26.7% | Stock Analytics | |
KAVERI SEED COMPANY | ₹7,349.6 Cr | -8.1% | 12.8% | 87.4% | Stock Analytics | |
BOMBAY SUPER HYBRID SEEDS | ₹1,429.6 Cr | -12.8% | 8.2% | -36.7% | Stock Analytics | |
MANGALAM GLOBAL ENTERPRISE | ₹434.0 Cr | -8.3% | -7.9% | NA | Stock Analytics | |
INDO US BIOTECH | ₹340.9 Cr | -1.9% | 8.4% | -29.5% | Stock Analytics |
VENKYS (INDIA) Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
VENKYS (INDIA) | -1.6% |
1% |
-2.2% |
SENSEX | 0.8% |
3.8% |
8.4% |
You may also like the below Video Courses